Titlebook: Immunopharmacology in Autoimmune Diseases and Transplantation; Hans Erik Rugstad,Liv Endresen,Øystein Førre Book 1992 Springer Science+Bus

entitle

The Immunologic Networkimmunologic network, a new immunopharmacology has been quietly developed over the past decade whose goals are more precise and defined treatment rationale with specific targeting of drugs to specific molecular sites.

知识分子

the basic sciences of immunology and pharmacology on the one hand and clinical medicine on the other. A further intention has been to emphasize those advances in immunology and pharmacology that are of clinical importance while retaining those facts that, while not new, remain clinically useful. Th

删除

CLOWN

notice

Human Immune Response Genesdy. Immunity is the successful outcome of this mechanism and its failure is progressive infection. Apart from the overt congenital or acquired immune deficiencies, there are also more subtle variations in the “resistance” of individuals to specific components of microorganisms that are under the con

小步舞

Accessory Cells as the main accessory cell for the various immune responses (Unanue, 1984). Later, however, it has become evident that a variety of other lymphoid cells like dendritic cells, resting and immune B cells, B cell lines or tumors, and major histocompatibility (MHC) class II-positive T cells also can ac

造反,叛乱

B Cells in Autoimmunityediated immunity. This means that to a large extent the antibody production is T-cell dependent. Many soluble products of both T helper cells and antigen-presenting cells (APC) (interleukins) have stimulatory effects on the proliferation and maturation of B cells.

游行

elastic

Dorsal